Showing 1 - 3 of 3
The ruling against the Kangmei Pharmaceutical Co., Ltd’s financial fraud was the first special representative action under China’s new Securities Law, serving as a milestone in investor protection in China. Exploiting the natural experiment provided by the ruling, we empirically test the...
Persistent link: https://www.econbiz.de/10014494085
Persistent link: https://www.econbiz.de/10011635127
Persistent link: https://www.econbiz.de/10003951546